Translational Research and Advanced Imaging Laboratory 

Innovative Medicines Initiative launches a new call

The Innovative Medicines Initiative (IMI) has launched a new Call for proposals, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.

The Call 7 includes the following topics:

- Validation of translational imaging methods in drug safety assessment (TRISTAN)

- Identification of druggable targets modulating misfolded proteins in Alzheimer’s and Parkinson’s diseases

- Pathological neuron-glia interactions in neuropathic pain

- Dry age-related macular degeneration: development of novel clinical endpoints for clinical trials with a regulatory and patient access intention 

- A comprehensive ‘paediatric preclinical POC platform’ to enable clinical molecule development for children with cancer

Details of Call 7 here

Text of Call 7 here


Dernière mise à jour vendredi 18 décembre 2015


HAUT